| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/19/2013 | US8377910 Immunoregulator compounds |
| 02/19/2013 | US8377895 Cyclin-dependent protein kinases inhibitors of Scutellaria flavonoid organic amine derivatives, synthesis and use thereof |
| 02/19/2013 | US8377893 Highly purified antiendotoxin compound |
| 02/19/2013 | US8377870 Antimicrobial aqueous solution and its preparation method |
| 02/19/2013 | US8377867 Use of epinecidin-1 peptides and anti-lipopolysaccharide factor peptides for treating microbial infection |
| 02/19/2013 | US8377483 Bioactivation of iron salt, especially an ferric ferrous salt, by adding a magnesium salt (MgCl2); useful as a medicine to treat diseases such as diabetes, freshness preservative agent, and animal and plant growth promoter |
| 02/19/2013 | US8377481 Apparatus and method to generate a mixture of hydrogen peroxide gas and a carrier gas |
| 02/19/2013 | US8377477 Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof |
| 02/19/2013 | CA2658877C Heme oxygenase inhibitors for the treatment of a microbial infection |
| 02/19/2013 | CA2634846C Novel arylamidine derivative, salt thereof and antifungal agent containing those |
| 02/19/2013 | CA2581493C Taste-masking pharmaceutical compositions |
| 02/19/2013 | CA2550013C Bactericide against streptococcus mutans and streptococcus sobrinus |
| 02/19/2013 | CA2520400C Treatment of aspergillus infections with thymosin alpha 1 |
| 02/19/2013 | CA2486187C Kinase inhibitors |
| 02/19/2013 | CA2467930C Treatment of pml targeting jc virus agno |
| 02/19/2013 | CA2388003C Expression of recombinant mature lysostaphin |
| 02/19/2013 | CA2375320C Dna vaccines for pets or for animals used in sports |
| 02/19/2013 | CA2276450C A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 02/19/2013 | CA2233570C Detection, prevention and treatment of papillomatous digital dermatitis |
| 02/14/2013 | WO2013023166A2 Hapivirins and diprovirins |
| 02/14/2013 | WO2013023062A1 Antimicrobial agents and methods for use thereof in the abatement of food borne pathogenic organisms |
| 02/14/2013 | WO2013022550A2 Small molecule inhibitors of ebola and lassa fever viruses |
| 02/14/2013 | WO2013021363A1 Quinazoline-2,4-dione derivatives |
| 02/14/2013 | WO2013021344A1 Imidazole derivatives as antiviral agents |
| 02/14/2013 | WO2013021337A1 Antiviral compounds with a fused tricyclic ring |
| 02/14/2013 | WO2013021258A1 Anti-tubercular compounds |
| 02/14/2013 | WO2013021054A1 Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones |
| 02/14/2013 | WO2013021052A1 Antibacterial piperidinyl substituted 3,4-dihydro-1h-[1,8]naphthyridinones |
| 02/14/2013 | WO2013021051A1 Antibacterial homopiperidinyl substituted 3,4 dihydro 1h [1,8]naphthyridinones |
| 02/14/2013 | WO2013020993A1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease |
| 02/14/2013 | WO2013020440A1 Amide derivate, and preparation method therefor, pharmaceutical composition and use thereof |
| 02/14/2013 | WO2013020246A1 Methylene derivatives of betulin |
| 02/14/2013 | WO2013020245A1 Carbonyl derivatives of betulin |
| 02/14/2013 | WO2013020183A1 Immunogenic compositions and methods therefor |
| 02/14/2013 | WO2013020164A1 Compounds for treating respiratory syncytial virus infections |
| 02/14/2013 | WO2012177020A9 Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof |
| 02/14/2013 | WO2012128501A9 Pharmaceutical composition containing, as an active ingredient, m-3m3fbs, which is an activator of phospholipase c, for preventing or treating inflammatory diseases or infectious diseases |
| 02/14/2013 | US20130042334 Capping-Prone RNA Polymerase Enzymes and Their Applications |
| 02/14/2013 | US20130041131 Glycosylated specificity exchangers |
| 02/14/2013 | US20130041023 Composition for Preventing or Treating Rotavirus Infection Comprising Licorice Extract |
| 02/14/2013 | US20130041008 Compounds for enzyme inhibition |
| 02/14/2013 | US20130040989 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid salts |
| 02/14/2013 | US20130040980 Cci-779 concentrate formulations |
| 02/14/2013 | US20130040976 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
| 02/14/2013 | US20130040961 Oligomer modified diaromatic substituted compounds |
| 02/14/2013 | US20130040960 Ophthalmic gel of gatifloxacin and preparation method thereof |
| 02/14/2013 | US20130040954 Pleuromutilin derivatives for the treatment of diseases mediated by microbes |
| 02/14/2013 | US20130040952 Influenza virus inhibitors that disrupt nucleoprotein trimerization |
| 02/14/2013 | US20130040928 Nitrogen heterocycle derivatives, preparation thereof and application thereof in human therapeutics |
| 02/14/2013 | US20130040924 Bridged polycyclic compound based compositions for the inhibition and amelioration of disease |
| 02/14/2013 | US20130040918 Tetracycline compositions |
| 02/14/2013 | US20130040914 Prodrugs of an hiv reverse transcriptase inhibitor |
| 02/14/2013 | US20130040905 Combination Of Drugs With Protein-Binding Prodrugs |
| 02/14/2013 | US20130040902 Method for enhancing milk quantity and quality |
| 02/14/2013 | US20130040900 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2013 | US20130040007 Antituberculosis composition of byttneria species |
| 02/14/2013 | US20130039997 Method for the eradication of pathogens including s. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells |
| 02/14/2013 | US20130039986 Silk-Based Ionomeric Compositions |
| 02/14/2013 | US20130039981 Quick Dissolving, Long Acting Zinc Therapeutic Formulations |
| 02/14/2013 | US20130039973 Viral Immunogenic Compositions |
| 02/14/2013 | US20130039970 Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics |
| 02/14/2013 | US20130039968 Materials and processes for producing antitoxic fabrics |
| 02/14/2013 | US20130039964 Metal entrapped bioactive composites |
| 02/14/2013 | US20130039959 Method of inhibiting hiv and barrier-forming composition therefor |
| 02/14/2013 | US20130039953 Method for treating a surface with a coating comprising a therapeutic agent and device with treated surface |
| 02/14/2013 | US20130039947 Novel immunogens and methods for discovery and screening thereof |
| 02/14/2013 | US20130039946 Vaccine comprising an attenuated pestivirus |
| 02/14/2013 | US20130039945 Anti-Viral Compounds |
| 02/14/2013 | US20130039944 Anti-Viral Compounds |
| 02/14/2013 | US20130039943 Novel method |
| 02/14/2013 | US20130039942 Compositions and Methods for Self-Adjuvanting Vaccines against Microbes and Tumors |
| 02/14/2013 | US20130039941 Vaccine comprising inactivated cells of haemophilus parasuis bacteria of serotype 5 |
| 02/14/2013 | US20130039939 Lipopeptide- and lipoprotein-conjugates and its use |
| 02/14/2013 | US20130039937 Peptide Sequences and Compositions |
| 02/14/2013 | US20130039933 Sting (stimulator of interferon genes), a regulator of innate immune responses |
| 02/14/2013 | US20130039928 Compositions and methods for reversing corticosteroid resistance or treating respiratory infections |
| 02/14/2013 | US20130039927 Antigenic mimics of discontinuous epitopes of pathogen recognized by broadly neutralizing antibodies |
| 02/14/2013 | US20130039926 Human antibodies against rabies and uses thereof |
| 02/14/2013 | US20130039924 Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases |
| 02/14/2013 | US20130039908 Prognostic markers and methods for prostate cancer |
| 02/14/2013 | US20130039906 PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE |
| 02/14/2013 | US20130039904 Gambogic acid cyclization analogues, their preparation method and application thereof |
| 02/14/2013 | US20130039902 Non-neurotoxic plasminogen activating factors for treating of stroke |
| 02/14/2013 | US20130039887 Methods of Identifying and Using Anti-Viral Compounds |
| 02/14/2013 | US20130039885 Leukotoxin e/d as a new anti-inflammatory agent and microbicide |
| 02/14/2013 | US20130039850 Heterologous antibodies which bind human cd4 |
| 02/14/2013 | US20130039848 Fluorescent silica-based nanoparticles |
| 02/14/2013 | CA2842885A1 Quinazoline-2,4-dione derivatives |
| 02/14/2013 | CA2842531A1 Antibacterial piperidinyl substituted 3,4-dihydro-1h-[1,8]naphthyridinones |
| 02/14/2013 | CA2842526A1 Antibacterial homopiperidinyl substituted 3,4-dihydro-1h-[1,8]naphthyridinones |
| 02/14/2013 | CA2842518A1 Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones |
| 02/14/2013 | CA2842123A1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease |
| 02/13/2013 | EP2557082A1 Cephem compound having catechol group |
| 02/13/2013 | EP2556835A1 Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism |
| 02/13/2013 | EP2556079A2 Polyol modified aminoglycoside-lipid conjugates |
| 02/13/2013 | EP2556063A1 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid salts |
| 02/13/2013 | EP2555798A1 Methods and compositions for inhibiting hiv transmission |
| 02/13/2013 | EP2555779A1 Glycomimetic compounds and methods to inhibit infection by hiv |
| 02/13/2013 | EP2555769A2 Methods for treating respiratory viral infection |
| 02/13/2013 | EP2555767A2 Methods of treatment using 3-bromopyruvate and other selective inhibitors of atp production |